| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9B | $4.8B | $4.3B | $3.6B | $3.1B | $0.6B | $0.6B | $0.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.1B | $1.0B | $0.9B | $0.7B | $0.6B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $3.37 | $3.48 | $3.07 | $2.38 | $2.08 | $0.34 | $0.27 | $0.00 |
| EPS (Diluted) | $3.16 | $3.46 | $3.05 | $2.37 | $2.07 | $0.34 | $0.27 | $0.00 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.0B | $17.6B | $14.9B | $14.0B | $9.8B | $9.0B | $7.6B | $6.7B |
| Current Assets | $8.6B | $6.9B | $5.1B | $5.0B | $3.3B | $3.0B | $2.5B | $2.2B |
| Cash & Equivalents | $1.1B | $0.7B | $0.7B | $0.7B | $0.9B | $0.8B | $0.5B | $0.4B |
| Total Liabilities | — | — | — | — | — | — | $3.9B | — |
| Current Liabilities | $8.3B | $6.3B | $5.0B | $4.6B | $2.7B | $2.4B | $2.0B | $1.8B |
| Stockholders' Equity | — | — | $5.6B | $4.6B | $4.2B | $3.8B | $3.4B | $3.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.2B | $1.0B | $0.9B | $0.9B | $0.7B | $0.7B | — |
| Investing Cash Flow | $-7.9B | $-0.9B | $-0.6B | $-1.9B | $-0.4B | $-0.8B | $-0.4B | — |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B | $0.0B |
| Financing Cash Flow | $7.7B | $-0.1B | $-0.2B | $1.7B | $-0.3B | $0.3B | $-0.1B | — |